Metastatic Leiomyosarcoma: Clinical Trials

1 trial for Metastatic Leiomyosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow Metastatic Leiomyosarcoma: new trials by email Literature Review of Metastatic Leiomyosarcoma trials Research Report on Metastatic Leiomyosarcoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
Cabozantinib, Quality-of-Life Assessment, Questionnaire Administration - Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma
Phase 2Active not recruitingCity of Hope Medical Center962020-01-142026-05-01

Narrower conditions

Leiomyosarcoma (1)  ·  Sarcoma (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Muscle Tissue (1)

Interventions

Temozolomide (1)  ·  cabozantinib (1)

Sponsors

City of Hope Medical Center (1)

Countries

United States (1)

Top investigators

Janet Yoon, MD (1)

Results publications

PMID 41554272

NIH funding

P30CA060553 (1)